WA
GCVRZ

WFG Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

WFG Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$0 Hold
75
– – ﹤0.01% 1774
2017
Q1 		$0 Hold
75
– – ﹤0.01% 1782
2016
Q4 		$0 Hold
75
– – ﹤0.01% 1876
2016
Q3 		$0 Hold
75
– – ﹤0.01% 1800
2016
Q2 		$0 Hold
75
– – ﹤0.01% 1814
2016
Q1 		$0 Hold
75
– – ﹤0.01% 1808
2015
Q4 		$0 Hold
75
– – ﹤0.01% 1783
2015
Q3 		$0 Hold
75
– – ﹤0.01% 1830
2015
Q2 		$0 Hold
75
– – ﹤0.01% 1933
2015
Q1 		$0 Hold
75
– – ﹤0.01% 2298
2014
Q4 		$0 Hold
75
– – ﹤0.01% 2387
2014
Q3 		$0 Hold
75
– – ﹤0.01% 2252
2014
Q2 		$0 Hold
75
– – ﹤0.01% 2185
2014
Q1 		$0 Hold
75
– – ﹤0.01% 2446
2013
Q4 		$0 Hold
75
– – ﹤0.01% 2442
2013
Q3 		$0 Hold
75
– – ﹤0.01% 2396
2013
Q2 		$0 Buy
+75
New +$132 ﹤0.01% 2172

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

WFG Advisors's GCVRZ Position: Q2 2017 in Review

WFG Advisors held its Sanofi Contingent Value Rights (GCVRZ) position steady in Q2 2017 at 75 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

WFG Advisors first reported a position in GCVRZ in Q2 2013 and has held it in 17 quarters since. 115 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2017.

  • WFG Advisors held 75 shares of Sanofi Contingent Value Rights worth $0 as of Q2 2017.
  • WFG Advisors left its Sanofi Contingent Value Rights share count unchanged in Q2 2017.
  • Sanofi Contingent Value Rights made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1774 holding.
  • WFG Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 17 quarters since.
  • 115 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.